NCT05901519View on ClinicalTrials.gov

A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 16, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Prednisone

Patients will be treated with PO prednisone, once a day, at a dose of 60 mg/day

Trial Locations (1)

48187

RECRUITING

Rogel Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER